Vor Biopharma Inc VOR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 02/03/23 EST
5.49quote price arrow up+0.08 (+1.48%)
Volume
60,317
52 week range
3.48 - 9.72
Loading...
  • Open5.41
  • Day High5.67
  • Day Low5.32
  • Prev Close5.41
  • 52 Week High9.72
  • 52 Week High Date02/22/22
  • 52 Week Low3.48
  • 52 Week Low Date10/11/22

Key Stats

  • Market Cap358.625M
  • Shares Out65.32M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-17.44

KEY STATS

  • Open5.41
  • Day High5.67
  • Day Low5.32
  • Prev Close5.41
  • 52 Week High9.72
  • 52 Week High Date02/22/22
  • 52 Week Low3.48
  • 52 Week Low Date10/11/22
  • Market Cap358.625M
  • Shares Out65.32M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-17.44

RATIOS/PROFITABILITY

  • EPS (TTM)-2.30
  • P/E (TTM)-2.39
  • Fwd P/E (NTM)-2.47
  • EBITDA (TTM)-84.698M
  • ROE (TTM)-44.13%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/13/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vor Biopharma Inc

 

Content From Our Affiliates

Profile

MORE
Vor Biopharma Inc. is a clinical-stage cell therapy company. The Company is engaged in combining a novel patient engineering approach with targeted therapies to provide solutions for patients suffering from hematological malignancies. Its proprietary platform leverages expertise in hematopoietic stem cell (HSC) biology, genome engineering and targeted therapy development to genetically modify HSCs to remove surface targets expressed by cancer cells. VOR33 is the lead product...
Matthew Patterson
Independent Chairman of the Board
Robert Ang M.D.
President, Chief Executive Officer, Director
Nathan Jorgensen Ph.D.
Chief Financial Officer
Address
100 Cambridgepark Drive, Suite 101
Cambridge, MA
02140
United States

Top Peers

SYMBOLLASTCHG%CHG
KALV
Kalvista Pharmaceuticals Inc
7.87+0.25+3.28%
OMIC
Singular Genomics Systems Inc
2.95+0.09+3.15%
LRMR
Larimar Therapeutics Inc
5.34+0.34+6.80%
CTXR
Citius Pharmaceuticals Inc
1.36UNCHUNCH
OLMA
Olema Pharmaceuticals Inc
4.55-0.32-6.57%